Related Experiment Videos
Co-trimoxazole-sensitive, methicillin-resistant Staphylococcus aureus, Israel, 1988-1997
Jihad Bishara1, Silvio Pitlik, Zmira Samra
1Department of Internal Medicine C, Rabin Medical Center, Beilinson Campus, Petach-Tikvah, Israel. bishara@netvision.net.il
Emerging Infectious Diseases
|October 2, 2003
Abstract:
Among bloodstream methicillin-resistant Staphylococcus aureus (MRSA) isolates from adult patients in a single hospital, susceptibility to co-trimoxazole increased progressively from 31% in 1988 to 92% in 1997 (p<0.0001). If also observed in other institutions, these findings should encourage the performance of a clinical trial of sufficient size to compare co-trimoxazole to vancomycin in treating MRSA infections.